WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank87
3Y CAGR+66.3%
5Y CAGR+14.1%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+66.3%/yr
Quarterly compound
5Y CAGR
+14.1%/yr
Recent acceleration
Percentile
P87
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.55% |
| Q3 2025 | 5.96% |
| Q2 2025 | -3.66% |
| Q1 2025 | 6.24% |
| Q4 2024 | -10.88% |
| Q3 2024 | 9.47% |
| Q2 2024 | 0.96% |
| Q1 2024 | 4.42% |
| Q4 2023 | -6.91% |
| Q3 2023 | 16.93% |
| Q2 2023 | -5.85% |
| Q1 2023 | -2.15% |
| Q4 2022 | 2.95% |
| Q3 2022 | 14.12% |
| Q2 2022 | -9.10% |
| Q1 2022 | -23.34% |
| Q4 2021 | -0.94% |
| Q3 2021 | 0.29% |
| Q2 2021 | 36.08% |
| Q1 2021 | -17.32% |
| Q4 2020 | 7.00% |
| Q3 2020 | 19.35% |
| Q2 2020 | -12.91% |
| Q1 2020 | -20.97% |
| Q4 2019 | 8.35% |
| Q3 2019 | -7.06% |
| Q2 2019 | 0.21% |
| Q1 2019 | -17.64% |
| Q4 2018 | -7.09% |
| Q3 2018 | 11.71% |
| Q2 2018 | 0.19% |
| Q1 2018 | 0.05% |
| Q4 2017 | -1.66% |
| Q3 2017 | 14.73% |
| Q2 2017 | 9.29% |
| Q1 2017 | -18.11% |
| Q4 2016 | -6.49% |
| Q3 2016 | -2.40% |
| Q2 2016 | 8.52% |
| Q1 2016 | -6.56% |